Status:
TERMINATED
Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)
Lead Sponsor:
UMC Utrecht
Collaborating Sponsors:
Free University Medical Center
Conditions:
in Vitro Fertilization
Ovulation Induction
Eligibility:
FEMALE
18-36 years
Phase:
PHASE4
Brief Summary
Background of the study: Milder stimulation protocols have the advantage of being less expensive and more patient-friendly. Moreover, recent evidence suggests that mild stimulation protocols lead to ...
Eligibility Criteria
Inclusion
- Female age \< 36 years
- FSH \< 12 IU/l
- BMI 18-29 kg/m2
- Regular cycle (25-35 days)
- No major uterine or ovarian abnormalities
- No previous IVF cycles
- Written informed consent
Exclusion
- Oocyte donation
- Medical contra indication for pregnancy or IVF treatment
- Endometriosis ≥ grade 3
- Polycystic Ovarium Syndrome (PCOS)
- Endocrine or metabolic abnormalities (pituitary, adrenal, pancreas, liver or kidney)
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
147 Patients enrolled
Trial Details
Trial ID
NCT00823472
Start Date
January 1 2009
End Date
October 1 2010
Last Update
January 29 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Brussel
Brussels, Belgium, 1090
2
University Medical Center Utrecht
Utrecht, Netherlands, 3508 GA